Case characteristics, definition, and related criteria for acute hemoglobinemia or hemoglobinuria
. | . | . | . | . | . | Acute hemoglobinemia or hemoglobinuria case definition (and related) criteria . | . | . | . | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Case no. . | Age, y . | Sex . | FDA received initial report . | Indication for anti-D IGIV . | Dose, μg/kg . | Acute* . | Hemoglobinemia† . | Hemoglobinuria‡ . | MD assessment§ . | |||
1 | 12 | M | May 1999 | ITP | 50 | —∥ | —¶ | Yes | Yes | |||
2 | 85 | M | Aug 1999 | ITP | 50 | Yes | Yes | Yes | Yes | |||
3 | 75 | M | Aug 2002 | ITP | 48 | Yes | —¶ | Yes | Yes | |||
4 | 25 | F | Sep 2003 | ITP | 50 | —∥ | —¶ | Yes | Yes | |||
5 | 71 | F | Sep 2004 | ITP | 75 | Yes | —¶ | Yes | Yes | |||
6 | 67 | M | Oct 2004 | ITP | 51 | Yes | —¶ | Yes | Yes |
. | . | . | . | . | . | Acute hemoglobinemia or hemoglobinuria case definition (and related) criteria . | . | . | . | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Case no. . | Age, y . | Sex . | FDA received initial report . | Indication for anti-D IGIV . | Dose, μg/kg . | Acute* . | Hemoglobinemia† . | Hemoglobinuria‡ . | MD assessment§ . | |||
1 | 12 | M | May 1999 | ITP | 50 | —∥ | —¶ | Yes | Yes | |||
2 | 85 | M | Aug 1999 | ITP | 50 | Yes | Yes | Yes | Yes | |||
3 | 75 | M | Aug 2002 | ITP | 48 | Yes | —¶ | Yes | Yes | |||
4 | 25 | F | Sep 2003 | ITP | 50 | —∥ | —¶ | Yes | Yes | |||
5 | 71 | F | Sep 2004 | ITP | 75 | Yes | —¶ | Yes | Yes | |||
6 | 67 | M | Oct 2004 | ITP | 51 | Yes | —¶ | Yes | Yes |
— indicates no information available.
Signs or symptoms within 4 hours of anti-D IGIV administration.
Increased serum hemoglobin level or anecdotal report of “visibly red serum” (or similar terms).
Positive urine reagent strip test for blood and urinary sediment with fewer RBCs than would correspond to degree of positivity of reagent strip or anecdotal report of “tea-colored urine” (or similar terms).
Attending or consulting physician assessment that hemoglobinemia or hemoglobinuria occurred.
Exact time of onset indeterminate due to incomplete medical history.
Relevant laboratory test results not available or not optimally timed.